GRIFOLS | GRF - Ebitda


GRIFOLS reported EUR505M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Alcon AG USD 728M 72M Sep/2026
Almirall EUR 80.45M 33.61M Jun/2026
Amadeus IT EUR 709.9M 37.1M Sep/2026
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 539M 6M Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Cie Automotive EUR 345.96M 35.96M Dec/2024
Demant DKK 2.8B 47M Jun/2026
Ence Energia y Celulosa EUR 45.97M 41.77M Sep/2026
Essilor EUR 4.34B 1.25B Jun/2026
Ferrovial EUR 294M 248M Jun/2026
Fresenius EUR 912M 76M Sep/2026
Fresenius Medical Care EUR 817M 26.66M Sep/2026
Genmab DKK 401M 186M Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 505M 32M Sep/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 2.94B 377M Jun/2026
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Merck EUR 1.68B 82.6M Sep/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 772M 138M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025
Viscofan EUR 73.16M 2.06M Sep/2026